Skip to main content

Durvalumab for Non Small Cell Lung Cancer User Reviews

Brand names: Imfinzi

Rating: 7.5

Durvalumab has an average rating of 7.5 out of 10 from a total of 4 reviews for the treatment of non small cell lung cancer. 75% of reviewers reported a positive experience, while 0% reported a negative experience.

10
25%
9
0%
8
50%
7
0%
6
0%
5
0%
4
25%
3
0%
2
0%
1
0%
  • Jef...
  • Taken for 5 to 10 years
  • November 25, 2024

Durvalumab "Also using to treat myeloma. Started taking late 2016. Seems to keep both cancers at bay. I have had some very strange lung infections. Not sure if related to treatment. My hair is very dry, thin, limp. Dry skin. Frequent urination. Fatigue. Restless nights. Depression. Body aches. I’m a 60-year-old male."

8 / 10
Was this helpful?YesNo
1 Report
  • jkp...
  • Taken for 6 months to 1 year
  • August 15, 2024

Durvalumab "Cancer in remission just before 10th treatment. Many skin problems. Dry, cracking skin on sides and bottom of feet. Dry skin on arms and legs. Occasional mild headaches, terrible problems sleeping at night. All problems on mild side."

10 / 10
Was this helpful?YesNo
1 Report
  • Dur...
  • Taken for 1 to 2 years
  • October 17, 2023

"During immunotherapy treatment for one year, I developed constipation, horrible itching all over my body with no relief from creams or any other treatments. Also, it shrunk my thyroid gland, so that I will have to stay on thyroid medicine for the rest of my life. I hope it worked on the cancer. We shall see."

4 / 10
Was this helpful?YesNo
0 Report

Frequently asked questions

  • Anonymous
  • Taken for 6 months to 1 year
  • April 1, 2024

Durvalumab "Had 12 treatments after completion of chemoradiation. Medication was well tolerated with minimal side effects."

8 / 10
Was this helpful?YesNo
2 Report

Are you taking this medicine?

Your review helps others make informed decisions.
Write a review
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.

Learn more about Non Small Cell Lung Cancer

Care guides